Oxygen Supplies Improved During COVID – Now Countries Need to Redeploy it to Other Conditions 05/05/2022 Maayan Hoffman The COVID-19 pandemic has increased the level of worldwide investment in respiratory care and now that cases are on the decline, countries need to develop long-term strategies to use oxygen, according to health experts. “Severe pneumonia, sepsis, trauma complications – there are many patients that would benefit from oxygen,” explained Janet Diaz, a team lead […] Continue reading -> What Worked to Reach Marginalised Communities During COVID-19? 04/05/2022 Aishwarya Tendolkar Protecting indigenous communities in Canada and refugees in central and Eastern Europe from COVID-19 requires community-based approaches that could be applied in other healthcare crises. This emerged from field actors who shared their experiences and lessons at the Geneva Health Forum on Tuesday. In Canada’s Manitoba province, indigenous communities were mistrustful of mass COVID-19 vaccinations, […] Continue reading -> Europe Must take advantage of ‘COVID-19 Ceasefire’ to Prepare for Next Wave, says WHO’s Kluge 04/05/2022 Maayan Hoffman The European Region and COVID-19 are in a “kind of ceasefire,” according to World Health Organization’s (WHO) Regional Director for Europe, Dr Hans Kluge. It is now up to the region’s 53 member states to take advantage of this window to prepare for the next fight, he said. “It is quiet and we have to […] Continue reading -> Four COVID-19 Lessons and How to Make Humanity More Resilient 04/05/2022 Maayan Hoffman The COVID-19 pandemic blindsided most of the world as it swept from China across the world at an unprecedent pace, infecting, ultimately killing millions of people. But more than two years later, there are some lessons that can be learned, said Tatiana Valovaya, director-general of the United Nations in Geneva on Tuesday evening. At the […] Continue reading -> People with Severe Psychiatric Disorders are Twice as Likely to Die from COVID 02/05/2022 Maayan Hoffman Individuals who suffer from severe psychiatric disorders were at least twice as likely to die from COVID-19 than others who caught the virus, at least in the first year of the pandemic when the most deadly SARS-COV2 variants, including Delta, were predominant. That is the key finding in a new study published in Molecular Psychiatry, […] Continue reading -> Fatal Outcomes for Two Confirmed Ebola Cases in DRC as Africa Strives to Reboot Immunization Strategies for COVID and Beyond 29/04/2022 Paul Adepoju In DR Congo’s latest Ebola outbreak, the two people with confirmed cases are dead and response is focusing on identifying and vaccinating contacts – because of insufficient doses to conduct a mass vaccination campaign in the outbreak area. Meanwhile, public health officials are trying to reboot Africa’s mainstream immunization programmes, which saw setbacks during the […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
What Worked to Reach Marginalised Communities During COVID-19? 04/05/2022 Aishwarya Tendolkar Protecting indigenous communities in Canada and refugees in central and Eastern Europe from COVID-19 requires community-based approaches that could be applied in other healthcare crises. This emerged from field actors who shared their experiences and lessons at the Geneva Health Forum on Tuesday. In Canada’s Manitoba province, indigenous communities were mistrustful of mass COVID-19 vaccinations, […] Continue reading -> Europe Must take advantage of ‘COVID-19 Ceasefire’ to Prepare for Next Wave, says WHO’s Kluge 04/05/2022 Maayan Hoffman The European Region and COVID-19 are in a “kind of ceasefire,” according to World Health Organization’s (WHO) Regional Director for Europe, Dr Hans Kluge. It is now up to the region’s 53 member states to take advantage of this window to prepare for the next fight, he said. “It is quiet and we have to […] Continue reading -> Four COVID-19 Lessons and How to Make Humanity More Resilient 04/05/2022 Maayan Hoffman The COVID-19 pandemic blindsided most of the world as it swept from China across the world at an unprecedent pace, infecting, ultimately killing millions of people. But more than two years later, there are some lessons that can be learned, said Tatiana Valovaya, director-general of the United Nations in Geneva on Tuesday evening. At the […] Continue reading -> People with Severe Psychiatric Disorders are Twice as Likely to Die from COVID 02/05/2022 Maayan Hoffman Individuals who suffer from severe psychiatric disorders were at least twice as likely to die from COVID-19 than others who caught the virus, at least in the first year of the pandemic when the most deadly SARS-COV2 variants, including Delta, were predominant. That is the key finding in a new study published in Molecular Psychiatry, […] Continue reading -> Fatal Outcomes for Two Confirmed Ebola Cases in DRC as Africa Strives to Reboot Immunization Strategies for COVID and Beyond 29/04/2022 Paul Adepoju In DR Congo’s latest Ebola outbreak, the two people with confirmed cases are dead and response is focusing on identifying and vaccinating contacts – because of insufficient doses to conduct a mass vaccination campaign in the outbreak area. Meanwhile, public health officials are trying to reboot Africa’s mainstream immunization programmes, which saw setbacks during the […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Europe Must take advantage of ‘COVID-19 Ceasefire’ to Prepare for Next Wave, says WHO’s Kluge 04/05/2022 Maayan Hoffman The European Region and COVID-19 are in a “kind of ceasefire,” according to World Health Organization’s (WHO) Regional Director for Europe, Dr Hans Kluge. It is now up to the region’s 53 member states to take advantage of this window to prepare for the next fight, he said. “It is quiet and we have to […] Continue reading -> Four COVID-19 Lessons and How to Make Humanity More Resilient 04/05/2022 Maayan Hoffman The COVID-19 pandemic blindsided most of the world as it swept from China across the world at an unprecedent pace, infecting, ultimately killing millions of people. But more than two years later, there are some lessons that can be learned, said Tatiana Valovaya, director-general of the United Nations in Geneva on Tuesday evening. At the […] Continue reading -> People with Severe Psychiatric Disorders are Twice as Likely to Die from COVID 02/05/2022 Maayan Hoffman Individuals who suffer from severe psychiatric disorders were at least twice as likely to die from COVID-19 than others who caught the virus, at least in the first year of the pandemic when the most deadly SARS-COV2 variants, including Delta, were predominant. That is the key finding in a new study published in Molecular Psychiatry, […] Continue reading -> Fatal Outcomes for Two Confirmed Ebola Cases in DRC as Africa Strives to Reboot Immunization Strategies for COVID and Beyond 29/04/2022 Paul Adepoju In DR Congo’s latest Ebola outbreak, the two people with confirmed cases are dead and response is focusing on identifying and vaccinating contacts – because of insufficient doses to conduct a mass vaccination campaign in the outbreak area. Meanwhile, public health officials are trying to reboot Africa’s mainstream immunization programmes, which saw setbacks during the […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Four COVID-19 Lessons and How to Make Humanity More Resilient 04/05/2022 Maayan Hoffman The COVID-19 pandemic blindsided most of the world as it swept from China across the world at an unprecedent pace, infecting, ultimately killing millions of people. But more than two years later, there are some lessons that can be learned, said Tatiana Valovaya, director-general of the United Nations in Geneva on Tuesday evening. At the […] Continue reading -> People with Severe Psychiatric Disorders are Twice as Likely to Die from COVID 02/05/2022 Maayan Hoffman Individuals who suffer from severe psychiatric disorders were at least twice as likely to die from COVID-19 than others who caught the virus, at least in the first year of the pandemic when the most deadly SARS-COV2 variants, including Delta, were predominant. That is the key finding in a new study published in Molecular Psychiatry, […] Continue reading -> Fatal Outcomes for Two Confirmed Ebola Cases in DRC as Africa Strives to Reboot Immunization Strategies for COVID and Beyond 29/04/2022 Paul Adepoju In DR Congo’s latest Ebola outbreak, the two people with confirmed cases are dead and response is focusing on identifying and vaccinating contacts – because of insufficient doses to conduct a mass vaccination campaign in the outbreak area. Meanwhile, public health officials are trying to reboot Africa’s mainstream immunization programmes, which saw setbacks during the […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
People with Severe Psychiatric Disorders are Twice as Likely to Die from COVID 02/05/2022 Maayan Hoffman Individuals who suffer from severe psychiatric disorders were at least twice as likely to die from COVID-19 than others who caught the virus, at least in the first year of the pandemic when the most deadly SARS-COV2 variants, including Delta, were predominant. That is the key finding in a new study published in Molecular Psychiatry, […] Continue reading -> Fatal Outcomes for Two Confirmed Ebola Cases in DRC as Africa Strives to Reboot Immunization Strategies for COVID and Beyond 29/04/2022 Paul Adepoju In DR Congo’s latest Ebola outbreak, the two people with confirmed cases are dead and response is focusing on identifying and vaccinating contacts – because of insufficient doses to conduct a mass vaccination campaign in the outbreak area. Meanwhile, public health officials are trying to reboot Africa’s mainstream immunization programmes, which saw setbacks during the […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fatal Outcomes for Two Confirmed Ebola Cases in DRC as Africa Strives to Reboot Immunization Strategies for COVID and Beyond 29/04/2022 Paul Adepoju In DR Congo’s latest Ebola outbreak, the two people with confirmed cases are dead and response is focusing on identifying and vaccinating contacts – because of insufficient doses to conduct a mass vaccination campaign in the outbreak area. Meanwhile, public health officials are trying to reboot Africa’s mainstream immunization programmes, which saw setbacks during the […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy